ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9 | -10.0% | 4,470 | 0.0% | 0.00% | – |
| Q2 2023 | $10 | -41.2% | 4,470 | -22.3% | 0.00% | -100.0% |
| Q1 2023 | $17 | -32.0% | 5,754 | -46.2% | 0.00% | 0.0% |
| Q4 2022 | $25 | -99.9% | 10,699 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $20,000 | -31.0% | 10,699 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -14.7% | 10,699 | -6.4% | 0.00% | -50.0% |
| Q1 2022 | $34,000 | -37.0% | 11,431 | -18.2% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | +17.4% | 13,982 | +0.6% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | -20.7% | 13,900 | -15.2% | 0.00% | -33.3% |
| Q4 2020 | $58,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |